Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Questionnaire for a biotech: NovaDigm Therapeutics.

Hennessey JP, Cooke T.

Hum Vaccin Immunother. 2013 Aug;9(8):1615-6. doi: 10.4161/hv.26190. Epub 2013 Aug 1. No abstract available.

2.

NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response.

Ibrahim AS, Luo G, Gebremariam T, Lee H, Schmidt CS, Hennessey JP Jr, French SW, Yeaman MR, Filler SG, Edwards JE Jr.

Vaccine. 2013 Nov 12;31(47):5549-56. doi: 10.1016/j.vaccine.2013.09.016. Epub 2013 Sep 21.

3.

A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine.

Sandini S, La Valle R, Deaglio S, Malavasi F, Cassone A, De Bernardis F.

FEMS Immunol Med Microbiol. 2011 Jul;62(2):215-24. doi: 10.1111/j.1574-695X.2011.00802.x. Epub 2011 Apr 28.

4.

Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.

Raska M, Belakova J, Horynova M, Krupka M, Novotny J, Sebestova M, Weigl E.

Med Mycol. 2008 Aug;46(5):411-20. doi: 10.1080/13693780701883508. Epub 2008 Mar 5.

PMID:
18608941
5.

Adjuvanticity of a recombinant calreticulin fragment in assisting anti-β-glucan IgG responses in T cell-deficient mice.

Li WJ, Long K, Dong HL, Gao XM.

Clin Vaccine Immunol. 2013 Apr;20(4):582-9. doi: 10.1128/CVI.00689-12. Epub 2013 Feb 13.

6.

Recent progress in vaccines against fungal diseases.

Cassone A, Casadevall A.

Curr Opin Microbiol. 2012 Aug;15(4):427-33. doi: 10.1016/j.mib.2012.04.004. Epub 2012 May 6. Review.

7.

A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models.

De Bernardis F, Amacker M, Arancia S, Sandini S, Gremion C, Zurbriggen R, Moser C, Cassone A.

Vaccine. 2012 Jun 22;30(30):4490-8. doi: 10.1016/j.vaccine.2012.04.069. Epub 2012 May 3.

PMID:
22561143
8.

A beta-glucan-conjugate vaccine and anti-beta-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique.

Pietrella D, Rachini A, Torosantucci A, Chiani P, Brown AJ, Bistoni F, Costantino P, Mosci P, d'Enfert C, Rappuoli R, Cassone A, Vecchiarelli A.

Vaccine. 2010 Feb 17;28(7):1717-25. doi: 10.1016/j.vaccine.2009.12.021. Epub 2009 Dec 25.

PMID:
20038431
9.
10.

Generation and immunity testing of a recombinant adenovirus expressing NcSRS2-NcGRA7 fusion protein of bovine Neospora caninum.

Jia LJ, Zhang SF, Qian NC, Xuan XN, Yu LZ, Zhang XM, Liu MM.

Korean J Parasitol. 2013 Apr;51(2):247-53. doi: 10.3347/kjp.2013.51.2.247. Epub 2013 Apr 25.

11.

Focal fungal infections treated by immunological therapy with emphasis on vaginal moniliasis.

Hosen H.

Tex Med. 1971 Oct;67(10):56-8. No abstract available.

PMID:
4938187
12.

Comparison of protective effect of protein and DNA vaccines hsp90 in murine model of systemic candidiasis.

Raska M, Beláková J, Wudattu NK, Kafková L, Růzicková K, Sebestová M, Kolár Z, Weigl E.

Folia Microbiol (Praha). 2005;50(1):77-82.

PMID:
15954537
13.

Fungal cell wall vaccines: an update.

Edwards JE Jr.

J Med Microbiol. 2012 Jul;61(Pt 7):895-903. doi: 10.1099/jmm.0.041665-0. Epub 2012 Jan 19. Review.

14.

Candida autovaccination in the treatment of vulvovaginal Candida infections.

Rusch K, Schwiertz A.

Int J Gynaecol Obstet. 2007 Feb;96(2):130. Epub 2007 Jan 18. No abstract available.

PMID:
17239379
15.

New immunotherapeutic strategies to control vaginal candidiasis.

Magliani W, Conti S, Cassone A, De Bernardis F, Polonelli L.

Trends Mol Med. 2002 Mar;8(3):121-6. Review.

PMID:
11879772
16.

Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA.

Shubitz L, Peng T, Perrill R, Simons J, Orsborn K, Galgiani JN.

Infect Immun. 2002 Jun;70(6):3287-9.

17.

Partial protection against experimental vaginal candidiasis after mucosal vaccination with heat-killed Candida albicans and the mucosal adjuvant LT(R192G).

Cárdenas-Freytag L, Steele C, Wormley FL Jr, Cheng E, Clements JD, Fidel PL Jr.

Med Mycol. 2002 Jun;40(3):291-9.

PMID:
12146759
18.

Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.

Li Wq, Hu Xc, Zhang X, Ge Y, Zhao S, Hu Y, Ashman RB.

Vaccine. 2011 Jul 26;29(33):5526-33. doi: 10.1016/j.vaccine.2011.05.030. Epub 2011 Jun 7.

PMID:
21645574
19.

Genetic basis for protection against experimental vaginal candidiasis by peripheral immunization.

Mulero-Marchese RD, Blank KJ, Sieck TG.

J Infect Dis. 1998 Jul;178(1):227-34.

PMID:
9652445
20.

Universal fungal vaccines: could there be light at the end of the tunnel?

Hamad M.

Hum Vaccin Immunother. 2012 Dec 1;8(12):1758-63. doi: 10.4161/hv.21838. Epub 2012 Aug 24. Review.

Supplemental Content

Support Center